GLG Partners’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$26.3M Sell
1,141,898
-103,276
-8% -$2.14M 1.23% 12
2017
Q3
$26.1M Buy
1,245,174
+890,042
+251% +$16.4M 1.38% 12
2017
Q2
$7.17M Buy
355,132
+354,145
+35,881% +$7.72M 0.4% 88
2017
Q1
$24K Buy
+987
New +$26.6K ﹤0.01% 443
2016
Q2
Sell
-987
Closed -$17K 473
2016
Q1
$17K Buy
+987
New +$14.7K ﹤0.01% 390
2015
Q3
Sell
-114,893
Closed -$2.16M 516
2015
Q2
$2.16M Sell
114,893
-556,007
-83% -$11.5M 0.06% 284
2015
Q1
$12.6M Buy
670,900
+28,015
+4% +$480K 0.42% 75
2014
Q4
$10.7M Buy
+642,885
New +$13.6M 0.31% 93
2014
Q3
Sell
-106,305
Closed -$3.71M 470
2014
Q2
$3.71M Buy
106,305
+22,744
+27% +$747K 0.09% 209
2014
Q1
$2.65M Buy
+83,561
New +$2.32M 0.05% 238

Other funds holding PTEN

GLG Partners's PTEN Position: Q4 2017 in Review

GLG Partners reduced its Patterson-UTI (PTEN) stake by 8.3% in Q4 2017, selling an estimated $2.14M and leaving 1,141,898 shares worth $26.3M. The position accounts for 1.23% of the portfolio, ranked #12.

GLG Partners first reported a position in PTEN in Q1 2014 and has held it in 10 quarters since. 324 funds tracked by Wall St. Rank hold PTEN as of Q4 2017.

  • GLG Partners held 1,141,898 shares of Patterson-UTI worth $26.3M as of Q4 2017.
  • GLG Partners sold 103,276 Patterson-UTI shares in Q4 2017, an estimated $2.14M.
  • Patterson-UTI made up 1.23% of GLG Partners's portfolio in Q4 2017, its #12 holding.
  • GLG Partners first reported a position in Patterson-UTI in Q1 2014 and has held it in 10 quarters since.
  • 324 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.